GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 851 - 875 of 4050 in total
Antibody Patient Onset (days) ▼ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G24617OK
492
IgA Patient 2 3 mild
G25407RZ
596
IgA Patient 2 3 mild
G25473LQ
469
IgA Patient 2 3 mild
G25559RS
1082
IgA Patient 2 3 mild
G26125KY
634
IgA Patient 2 3 mild
G26295XE
368
IgA Patient 2 3 mild
G27689OB
470
IgA Patient 2 3 mild
G28868ZC
250
IgA Patient 2 3 mild
G29011JC
655
IgA Patient 2 3 mild
G29857RC
510
IgA Patient 2 3 mild
G30839DN
483
IgA Patient 2 3 mild
G31265MS
456
IgA Patient 2 3 mild
G32473MI
500
IgA Patient 2 3 mild
G32611KT
275
IgA Patient 2 3 mild
G32699RJ
469
IgA Patient 2 3 mild
G35446HX
3193
IgA Patient 2 3 mild
G36191CD
530
IgA Patient 2 3 mild
G36374CE
356
IgA Patient 2 3 mild
G36544AC
1007
IgA Patient 2 3 mild
G37036SF
340
IgA Patient 2 3 mild
G37383BH
313
IgA Patient 2 3 mild
G38488WF
366
IgA Patient 2 3 mild
G39023AU
314
IgA Patient 2 3 mild
G39213VZ
699
IgA Patient 2 3 mild
G40696TO
303

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024